Academic Journal
Q1Transplantation and Cellular Therapy
About Transplantation and Cellular Therapy
Transplantation and Cellular Therapy is a scholarly journal published by Elsevier B.V.. SCImago 2025 places it in Q1 with an SJR of 2.251 and an H-index of 152.
Its listed coverage is 2021-2026 and its research categories include Cell Biology (Q1); Hematology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Transplantation (Q1). The 2025 dataset reports 293 documents and 3941 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, CAR-T cell therapy research, Immune Cell Function and Interaction, Renal Transplantation Outcomes and Treatments.
Recent Research Articles
Latest publications matched automatically by ISSN.
A New Standard in Graft-versus-Host Disease Prophylaxis? An Introduction to Blood and Marrow Transplant Clinical Trials Network 1703
Zachariah DeFilipp, Linda J. Burns, Samantha M. Jaglowski, Aaron L. Leppin et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.08.029Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35
Francesca Ulbar, Ida Villanova, Raffaella Giancola, Stefano Baldoni et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.08.034Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age
Colin Flannelly, Bryan E-Xin Tan, Jian Liang Tan, Colin M. McHugh et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.09.013Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Fanconi Anemia: Improving Outcomes with Improved Supportive Care in India
Ramya Uppuluri, Venkateswaran Vellaichamy Swaminathan, Kesavan Melarcode Ramanan, Satishkumar Meena et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.08.019Outcomes of Autologous Stem Cell Transplant Consolidation in Primary Central Nervous System Lymphoma: A Mayo Clinic Experience
Arushi Khurana, Ivana N. Micallef, Betsy R. LaPlant, Brian Patrick O’Neill et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.08.012Clinical and Neuroimaging Correlates of Post-Transplant Delirium
Patrick Smith, Jillian C. Thompson, Elena Perea, Brian Wasserman et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.09.016Individuals, Boundaries, and Graft-versus-Host Disease
H. Joachim Deeg
2020-12 · DOI: 10.1016/j.bbmt.2020.09.001Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation for Mature T Cell and Natural Killer Cell Neoplasms in the Kyoto Stem Cell Transplantation Group
Mizuki Watanabe, Junya Kanda, Yasuyuki Arai, Masakatsu Hishizawa et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.07.032Goal-Oriented Monitoring of Cyclosporine Is Effective for Graft-versus-Host Disease Prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia Major
Alexandra Gauthier, Nathalie Bleyzac, Nathalie Garnier, Kamila Kebaili et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.01.016Posterior Reversible Encephalopathy Syndrome after Allogeneic Stem Cell Transplantation in Pediatric Patients with Fanconi Anemia, a Prospective Study
Maryam Behfar, Mohammad Babaei, Amir Reza Radmard, Soheil Kooraki et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.08.021Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous Leukemia
Karamjeet S. Sandhu, Sanjeet Dadwal, Dongyun Yang, Matthew Mei et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.08.027Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents
Christopher Lemieux, Laura J. Johnston, Robert Lowsky, Lori S. Muffly et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.08.035Officers and Directors of ASTCT
2020-12 · DOI: 10.1016/s1083-8791(20)30705-9Use of Potentially Inappropriate Medications in Older Allogeneic Hematopoietic Cell Transplantation Recipients
Divya Bhargava, Mukta Arora, Todd E. DeFor, Claudio G. Brunstein et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.08.031Prognostic Impact of Cytogenetic Evolution on the Outcome of Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Nonremission: A Single-Institute Analysis of 212 Recipients
Mitsuhiro Yuasa, Hisashi Yamamoto, Takashi Mitsuki, Kosei Kageyama et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.08.026Costs of Cord Blood Transplantation Are Higher Than Other Graft Sources in Patients with Acute Leukemia and Myelodysplastic Syndrome Treated at Pediatric Centers
Hemalatha G. Rangarajan, Joseph R. Stanek, Rolla Abu-Arja
2020-12 · DOI: 10.1016/j.bbmt.2020.09.011The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study
Andrew J. Cowan, Helen Baldomero, Yoshiko Atsuta, Joseph Mikhael et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.08.018Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System Analysis
Avirup Guha, Daniel Addison, Prantesh Jain, Jahir M. Gutierrez et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.08.036A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma
Lauren Shea, Marcus P. Watkins, Fei Wan, Amanda F. Cashen et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.08.017Peritransplantation Use of Ruxolitinib in Myelofibrosis
Uroosa Ibrahim, Giulia Eva Maria Petrone, John Mascarenhas, Alla Keyzner et al.
2020-12 · DOI: 10.1016/j.bbmt.2020.08.015Reviews
Community Reviews
Version History
September 8, 2026 at 12:07 am
September 8, 2026